Atefeh Abedini,^1,2,* David A. Landry,^1,2,3,**,* Angus D. Macaulay,⁴ Het Vaishnev,^1,2 Ashna Parbhakar,² Dalia Ibrahim,^1,2 Reza Salehi,⁴ Vincent Maranda,^1,2 Elizabeth MacDonald,^1,2 Barbara C. Vanderhyden<sup>1,2,**

1</sup>Department of Cellular and Molecular Medicine, University of Ottawa, Ottawa, ON, Canada
²Cancer Therapeutics Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada
³Interdisciplinary School of Health Sciences, University of Ottawa, Ottawa, ON, Canada
⁴Chronic Diseases Program, Ottawa Hospital Research Institute, Ottawa, ON, Canada

^*These authors contributed equally: Atefeh Abedini and David A. Landry.
^**Correspondence: Cancer Therapeutics Program, Ottawa Hospital Research Institute, 501 Smyth Road, Box 926, Ottawa, ON K1H 8L6, Canada. E-mail: dlandry5@uottawa.ca (David A. Landry) or E-mail: bvanderhyden@ohri.ca (Barbara C. Vanderhyden)